Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-322 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-111 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K20-111 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 |
filingDate |
2020-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2022-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2022-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-102427769-B1 |
titleOfInvention |
Composition for prevention or treatment of multiple sclerosis |
abstract |
The present invention provides for the prevention of multiple sclerosis comprising (S)-2-((4'-(trifluoromethyl)biphenyl-4-yl)methylamino)propanamide or a pharmaceutically acceptable salt thereof as an active ingredient , improvement or therapeutic use. |
priorityDate |
2020-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |